Skip to search.
 FTSE 100 Down 1.27%

Amicus Therapeutics, Inc. (FOLD)

-NasdaqGM
7.50 Up 0.03(0.33%) 20:30 - Nasdaq Real Time Price
Prev Close:7.47
Open:7.51
Bid:7.53 x 600
Ask:7.54 x 700
1y Target Est:13.29
Beta:1.35463
Next Earnings Date: 3-May-16FOLD Earnings announcement
Day's Range:7.31 - 7.70
52wk Range:4.99 - 18.83
Volume:1,622,181
Avg Vol (3m):2,626,230
Market Cap:946.31m
P/E (ttm):N/A
EPS (ttm):-1.20
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

  • No Headlines available for FOLD at this time.

Comparison

Symbol% ChgMkt Cap
FOLDUp 0.33%946.31m

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :-1.44
Quarterly EPS Est (Mar-16) :-0.34
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Amicus Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines for various rare and orphan diseases. more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback